| 2026-03-30 |
IGLBMU31088MDSAV |
MACLEODS PHARMA USA INC |
6964.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG CT HSN: R IZATRIPTAN BENZOATE MG TABLETS HSN: PRAMIPAXOLE DIHYDROCHLORIDE EXTENDED RELEASE USP .MG TABLETS HSN: RISEDRONATE SODIUM USP MG TABLETS HSN: LOSART AN POTASSIUM MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: METHIMAZOLE TABLETS USP MG S COUNT HSN: AMLODIPINE AN D VALSARTAN TABLETS USP MGMG S HSN: |
| 2026-03-30 |
IGLBMU31089MDSAV |
MACLEODS PHARMA USA INC |
7852.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HCL MG TA BLETS HSN: PIOGLITAZONE USP MG TAB LETS HSN: PRAMIPEXOLE DIHYDROCHLORID E EXTENDED RELEASE TABLETS USP . MG HSN: RISEDRONATE SODIUM USP MG TABLETS H SN: LOSARTAN POTASSIUM MG HYDROCH LOROTHIAZIDE .MG TABLETS HSN: AML ODIPINE AND VALSARTAN TABLETS USP MGMG S HSN: |
| 2026-03-30 |
IGLBMU31090MDSAV |
MACLEODS PHARMA USA INC |
8471.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT LOSARTAN POTASSIUM AND HYDROCHLOROT HIAZIDE TABLETS USP MG. MG CT HSN: MEMANTINE HCL MG TABLETS HSN: PIOGLITAZONE HYDROCHLORIDE TABLETS USP MG CT HSN: OLMESARTAN MEDOXOMIL TABLETS, USP MG USA S COUNT HSN: NEVIRAPINE EXTENDED RELEASE MG TABLETS HSN: LOSARTAN POTASSIUM MG HYDROC HLOROTHIAZIDE .MG TABLETS HSN: ME THIMAZOLE TABLETS USP MG S COUNT HSN: CELECOXIB CAPSULES MG S COUNT C ONTAINER PACK HSN: |
| 2026-03-29 |
SQXNBOMS26028810 |
MACLEODS PHARMA USA INC |
7726.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-24 |
IGLBMU31030NHSAV |
MACLEODS PHARMA USA INC |
7185.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-23 |
EXDO62C0279993 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
5756.0 kg |
520300.0
|
EMTRICITABINE MG AND TENOFOVIR HTS: |
| 2026-03-23 |
IGLBMU31084MDSAV |
MACLEODS PHARMA USA INC |
7725.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HYDROCHLORI DE MG TABLETS HSN: OLANZAPINE MG USP TABLETS HSN: PRAMIPEXOLE DIHYDR OCHLORIDE EXTENDED RELEASE TABLETS . MG CT HSN: DARIFENACIN EXTENDED:RELEASE TABLETS MG S HSN: SACUBITRIL AND VALSARTAN TABLETS MG MG |
| 2026-03-23 |
IGLBMU31087MDSAV |
MACLEODS PHARMA USA INC |
9712.0 kg |
902230.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P ATORVASTAT IN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABL QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABL ETS QUANTITY : X X TABS ATORVASTAT IN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTI TY : X X TABS ATORVASTATIN MG TA BLETS QUANTITY : X X TABS HSN CODE: |
| 2026-03-23 |
IGLBMU31086MDSAV |
MACLEODS PHARMA USA INC |
8649.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE OINTMENT USP . WW HSN: REPAGLINIDE TABLETS USP .MG S COUNTS HSN: CLOBETASOL PROPIONATE OINTMENT USP .% ALUMINUM TUBE : G CLOBETASOL PRO PIONATE OINTMENT USP .% ALUMINUM TUBE : GM CLOBETASOL PROPIONATE OINTMENT USP .% A LUMINUM TUBE : G HSN: |
| 2026-03-22 |
SQXNBOMS26029103 |
MACLEODS PHARMA USA INC |
8379.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-17 |
IGLBMU30983NHSAV |
MACLEODS PHARMA USA INC |
7877.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO. P IRBESARTA N MG HYDROCHLOROTHIAZIDE .MG TABLETS IRBESARTAN MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: LAMIVUDINE TABLETS, US P MG CT HSN: OLMESARTAN MEDOX OMIL AND HYDROCHLOROTHIAZIDE TABLETS MG. MG S HSN: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE TABLETS MGMG HSN: IRBESARTAN :HYDROCHLOROTHIAZIDE TAB LETS USP .MG CT HSN: FEBUXOS TAT TABLETS MG S HSN: |
| 2026-03-17 |
IGLBMU30979NHSAV |
MACLEODS PHARMA USA INC |
8499.0 kg |
280511.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO. P LEVOTHYRO XINE SODIUM TABLETS USP MCG -S LEVOTHY ROXINE SODIUM TABLETS USP MCG - S LEVO THYROXINE SODIUM TABLETS USP MCG - S LE VOTHYROXINE SODIUM TABLETS USP MCG - LEVOTHYROXINE SODIUM TABLETS USP MCG - S HSN CODE: |
| 2026-03-17 |
IGLBMU31002MDSAV |
MACLEODS PHARMA USA INC |
8490.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P PIOGLITAZO NE USP MG TABLETS HSN: OLANZAPINE .MG USP TABLETS OLANZAPINE MG USP TABLETS HSN: DARIFENACIN EXTENDED:RELEASE TA BLETS MG S HSN: |
| 2026-03-17 |
IGLBMU31017MDSAV |
MACLEODS PHARMA USA INC |
7108.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P PIOGLITAZO NE HYDROCHLORIDE TABLETS USP MG USA COMMER CIAL S HSN: OLANZAPINE MG USP TA BLETS HSN: OLANZAPINE TABLETS USP MG CT HSN: LOSARTAN POTASSIUM MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: SACUBITRIL AND VALSARTAN TABLETS M G MG USA HSN: |
| 2026-03-17 |
IGLBMU31016MDSAV |
MACLEODS PHARMA USA INC |
9373.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HCL MG TA BLETS HSN: PIOGLITAZONE HYDROCHLORID E TABLETS USP MG USA PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG USA HSN: PIO GLITAZONE USP MG TABLETS OLANZAPINE MG US P TABLETS OLANZAPINE MG USP TABLETS HSN: TAMSULOSIN HYDROCHLORIDE CAPSULES USP .M HSN: DARIFENACIN EXTENDED:RELEA SE TABLETS MG S HSN: SACUBITRIL AND VALSARTAN TABLETS MG MG HSN: |
| 2026-03-17 |
IGLBMU30994MDSAV |
MACLEODS PHARMA USA INC |
7600.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW QUANTITY : X X GM HSN CODE: LIDOCAINE OINT MENT USP HSN CODE: |
| 2026-03-12 |
NXGWICDDJJ75663 |
MACLEODS PHARMA USA INC |
7532.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-12 |
NXGWICDDJJ76864 |
MACLEODS PHARMA USA INC |
7058.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-11 |
NXGWICDDJB47961 |
MACLEODS PHARMA USA INC |
4374.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-11 |
NXGWICDDJB48436 |
MACLEODS PHARMA USA INC |
4144.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-08 |
NXGWICDDHY33600 |
MACLEODS PHARMA USA INC |
5691.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-08 |
NXGWICDDHY46955 |
MACLEODS PHARMA USA INC |
8415.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-06 |
NXGWICDDJD65145 |
MACLEODS PHARMA USA INC |
9169.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-06 |
NXGWICDDJD68402 |
MACLEODS PHARMA USA INC |
11223.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-03 |
NXGWICDDHP51710 |
MACLEODS PHARMA USA INC |
11474.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-03 |
NXGWICDDHP51942 |
MACLEODS PHARMA USA INC |
13154.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-03 |
NXGWICDDHP52001 |
MACLEODS PHARMA USA INC |
5143.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-03 |
NXGWICDDHP52340 |
MACLEODS PHARMA USA INC |
4706.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-03 |
NXGWICDDHP52561 |
MACLEODS PHARMA USA INC |
6779.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-02 |
NXGWICDDHW76763 |
MACLEODS PHARMA USA INC |
8836.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-02 |
NXGWICDDHW76984 |
MACLEODS PHARMA USA INC |
8663.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-02-28 |
IGLBMU30862MDSAV |
MACLEODS PHARMA USA INC |
8925.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW HSN: FLUOCINONIDE TOPICAL SOLUTION .% ML BOTT LE HSN: TRIAMCINOLONE ACETONIDE OINTM ENT USP . WW HSN: |
| 2026-02-28 |
IGLBMU30871MDSAV |
MACLEODS PHARMA USA INC |
8995.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN P OTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS USP MGMG CT HSN: OLANZAPINE TABL ETS USP MG CT HSN: LOSARTAN POT ASSIUM MG HYDROCHLOROTHIAZIDE MG TABLETS HSN: METHIMAZOLE TABLETS USP MG H SN: |
| 2026-02-28 |
IGLBMU30902MDSAV |
MACLEODS PHARMA USA INC |
11598.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P CLOBETASOL PROPIONATE TOPICAL SOLUTION USP . WW HSN: TRIAMCINOLONE ACETONIDE CREAM USP . WW TRIAMCINOLONE ACETONIDE CREAM USP . W W HSN: LIDOCAINE OINTMENT USP HSN: |
| 2026-02-28 |
IGLBMU30888MDSAV |
MACLEODS PHARMA USA INC |
10361.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P CLOBETASOL PROPIONATE TOPICAL SOLUTION USP . WW HSN: TRIAMCINOLONE ACETONIDE OINTMENT US P . WW HSN: |
| 2026-02-28 |
IGLBMU30886MDSAV |
MACLEODS PHARMA USA INC |
4740.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-02-28 |
IGLBMU30915MDSAV |
MACLEODS PHARMA USA INC |
6347.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P & P DONEPEZIL HYDROCHLORIDE TABLETS MG S DONEPEZIL HYDROCHLORIDE TABLETS MG S HSN : RISEDRONATE SODIUM TABLETS USP M G S USACOMMERCIAL HSN: OLANZAPINE .MG USP TABLETS HSN: OLMESARTAN ME DOXOMIL TABLETS, USP MG USA S COUNT HSN: METHIMAZOLE TABLETS USP MG S COUNT HSN: |
| 2026-02-24 |
IGLBMU30822NHSAV |
MACLEODS PHARMA USA INC |
6943.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO. P IRBESARTA N MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: SILODOSIN MG CAPSULES SILODOSI N MG CAPSULES EACH CAPSULE CONTAINS NET CONE TENT OF MG SILODOSIN HSN: TADALAFIL TABLETS USP MG CT TADALAFI |
| 2026-02-23 |
IGLBMU30795MDSAV |
MACLEODS PHARMA USA INC |
7255.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P MEMANTINE HYDROCHLORIDE MG TABLETS MEMANTINE HCL MG TABLETS HSN: AMLODIPINE MG AND OLM ESARTAN MG TABLETS HSN: LOSARTAN P OTASSIUM MG HYDROCHLOROTHIAZIDE .MG TAB LETS HSN: SEVELAMER CARBONATE |
| 2026-02-23 |
IGLBMU30797MDSAV |
MACLEODS PHARMA USA INC |
8199.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P MEMANTINE HYDROCHLORIDE MG TABLETS HSN: OLA NZAPINE TABLETS USP MG CT HSN: O LANZAPINE TABLETS USP MG CT OLANZAPINE T ABLETS USP MG CT HSN: DARIFENA CIN EXTENDED:RELEASE TABLETS .MG S HSN: SA |
| 2026-02-23 |
IGLBMU30794MDSAV |
MACLEODS PHARMA USA INC |
4843.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN P OTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS USP MGMG CT HSN: RIZATRIPTAN BEN ZOATE MG TABLETS HSN: |
| 2026-02-23 |
IGLBMU30787MDSAV |
MACLEODS PHARMA USA INC |
7339.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P MEMANTINE HYDROCHLORIDE MG TABLETS MEMANTINE HCL MG TABLETS HSN: OLANZAPINE .MG USP T ABLETS HSN: OLMESARTAN MEDOXOMIL TAB LETS, USP MG USA S HSN: DARIFEN ACIN EXTENDED:RELEASE TABLETS .MG S |
| 2026-02-23 |
IGLBMU30800MDSAV |
MACLEODS PHARMA USA INC |
8494.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P MEMANTINE HCL MG TABLETS HSN: OLANZAPINE TAB LETS USP MG CT OLANZAPINE TABLETS USP MG CT HSN: OLMESARTAN MEDOXOMIL TABLETS, USP MG USA S HSN: DAR IFENACIN EXTENDED:RELEASE TABLETS .MG S H SN: |
| 2026-02-21 |
SQXNBOMS26017475 |
MACLEODS PHARMA USA INC |
5687.0 kg |
300510.0
|
PHARMACEUTICAL |
| 2026-02-17 |
IGLBMU30516MDSAV |
MACLEODS PHARMA USA INC |
8376.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P CLOBETASOL PROPIONATE TOPICAL SOLUTION USP . WW HSN: TRIAMCINOLONE ACETONIDE OINTMENT USP . WW HSN: LIDOCAINE OINTMENT USP LIDOCAINE OINTMENT USP QUANTITY : X X GM HSN: |
| 2026-02-17 |
NXGWICDDHN16086 |
MACLEODS PHARMA USA INC |
8633.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-02-17 |
NXGWICDDHN17770 |
MACLEODS PHARMA USA INC |
11654.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-02-15 |
IGLBMU30756MDSAV |
MACLEODS PHARMA USA INC |
2867.0 kg |
902230.0
|
CARTONS IN PACKAGES PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LACOSAMIDE TABLETS USP MG QUANTITY : X X TABS NDC NO. -- LACOSAMIDE TABLETS USP MG QUANTITY : X X TABS ND C NO. -- LACOSAMIDE TABLETS USP MG QUANTITY : X X TABS NDC NO. -- LACOSAMIDE TABLETS |
| 2026-02-15 |
IGLBMU30742MDSAV |
MACLEODS PHARMA USA INC |
6329.0 kg |
902230.0
|
CARTONS IN PACKAGES PHARMACEUTICAL PR ODUCTS AS PER INVOICE NO P OLANZAPIN E MG USP TABLETS QUANTITY : X X T ABS NDC NO. -- OLANZAPINE MG USP TABLETS QUANTITY : X X TABS NDC NO. -- FDA CODE N C A ANDA CODE HSN- OLANZAPINE ODT MG USP TA BLETS QUANTITY : X |
| 2026-02-15 |
IGLBMU30737MDSAV |
MACLEODS PHARMA USA INC |
9286.0 kg |
902230.0
|
CARTONS IN PACKAGES PHARMACEUTICAL PR ODUCTS AS PER INVOICE NO P TRIAMCINO LONE ACETONIDE CREAM USP . WW GM QUANTITY : X X GM NDC NO -- TRIAM CINOLONE ACETONIDE CREAM USP . WW QUANTITY : X X GM NDC NO.-- FDA COD E L C J ANDA CODE HSN- T RIAMCINOLONE ACETO |